{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:05:24Z","timestamp":1768421124691,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tampere University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04573-2","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T04:04:59Z","timestamp":1765425899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperuricemic persons use more analgesics than normouricemic\u2014is asymptomatic hyperuricemia really asymptomatic?"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0858-0412","authenticated-orcid":false,"given":"Janis","family":"Timsans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenni Emilia","family":"Kauppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vappu","family":"Rantalaiho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kerola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kia","family":"Hakkarainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiina","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Kautiainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Kauppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"4573_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8\u201314. https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.109.","journal-title":"Int J Cardiol"},{"key":"4573_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397:1843\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9.","journal-title":"Lancet"},{"key":"4573_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76:29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707.","journal-title":"Ann Rheum Dis"},{"key":"4573_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/art.41247","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol. 2020;72:879\u201395. https:\/\/doi.org\/10.1002\/art.41247.","journal-title":"Arthritis Rheumatol"},{"key":"4573_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jbspin.2020.05.002","volume":"87","author":"T Pascart","year":"2020","unstructured":"Pascart T, Latourte A, Flipo RM, et al. 2020 recommendations from the French Society of Rheumatology for the management of gout: urate-lowering therapy. Joint Bone Spine. 2020;87:395\u2013404. https:\/\/doi.org\/10.1016\/j.jbspin.2020.05.002.","journal-title":"Joint Bone Spine"},{"key":"4573_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o1754","volume":"378","author":"J Neilson","year":"2022","unstructured":"Neilson J, Bonnon A, Dickson A, Roddy E, Guideline Committee. Gout: diagnosis and management-summary of NICE guidance. BMJ. 2022;378:o1754. https:\/\/doi.org\/10.1136\/bmj.o1754.","journal-title":"BMJ"},{"key":"4573_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/10600280211032295","volume":"56","author":"L Brunetti","year":"2022","unstructured":"Brunetti L, Vekaria J, Lipsky PE, Schlesinger N. Treatment of acute gout flares in the emergency department: prescribing patterns and revisit rates. Ann Pharmacother. 2022;56:422\u20139. https:\/\/doi.org\/10.1177\/10600280211032295.","journal-title":"Ann Pharmacother"},{"key":"4573_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/acr.23928","volume":"72","author":"DS Dalal","year":"2020","unstructured":"Dalal DS, Mbuyi N, Shah I, Reinert S, Hilliard R, Reginato A. Prescription opioid use among patients with acute gout discharged from the emergency department. Arthritis Care Res (Hoboken). 2020;72:1163\u20138. https:\/\/doi.org\/10.1002\/acr.23928.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4573_CR9","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s10067-020-05085-5","volume":"39","author":"TK Oh","year":"2020","unstructured":"Oh TK, Song IA. Long-term opioid use among patients with chronic gout: a cross-sectional study of a sample cohort in South Korea. Clin Rheumatol. 2020;39:3033\u20139. https:\/\/doi.org\/10.1007\/s10067-020-05085-5.","journal-title":"Clin Rheumatol"},{"key":"4573_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247616","volume":"13","author":"J Timsans","year":"2024","unstructured":"Timsans J, Palom\u00e4ki A, Kauppi M. Gout and hyperuricemia: a narrative review of their comorbidities and clinical implications. J Clin Med. 2024;13:7616. https:\/\/doi.org\/10.3390\/jcm13247616.","journal-title":"J Clin Med"},{"key":"4573_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/biom11020280","volume":"11","author":"WZ Zhang","year":"2021","unstructured":"Zhang WZ. Why does hyperuricemia not necessarily induce gout? Biomolecules. 2021;11:280. https:\/\/doi.org\/10.3390\/biom11020280.","journal-title":"Biomolecules"},{"key":"4573_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-072110","volume":"13","author":"J Timsans","year":"2023","unstructured":"Timsans J, Kauppi JE, Kerola AM, Lehto TM, Kautiainen H, Kauppi MJ. Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population. BMJ Open. 2023;13:e072110. https:\/\/doi.org\/10.1136\/bmjopen-2023-072110.","journal-title":"BMJ Open"},{"key":"4573_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1876386301609010015","volume":"9","author":"HU Comberg","year":"2016","unstructured":"Comberg HU, Schach S. Hyperuricemia is associated with musculo-skeletal pain: results from a cross-sectional study. Open Pain J. 2016;9:15\u201325. https:\/\/doi.org\/10.2174\/1876386301609010015.","journal-title":"Open Pain J"},{"key":"4573_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221474","volume":"14","author":"H Jonsson","year":"2019","unstructured":"Jonsson H, Aspelund T, Eiriksdottir G, Harris TB, Launer LJ, Gudnason V. Hyperuricemia is associated with intermittent hand joint pain in a cross sectional study of elderly females: the AGES-Reykjavik Study. PLoS One. 2019;14:e0221474. https:\/\/doi.org\/10.1371\/journal.pone.0221474.","journal-title":"PLoS One"},{"key":"4573_CR15","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.mayocp.2024.07.011","volume":"99","author":"J Timsans","year":"2024","unstructured":"Timsans J, Kerola AM, Rantalaiho VM, Hakkarainen KN, Kautiainen HJ, Kauppi MJ. Metabolic\" type of hyperuricemia increases mortality mainly by leading to premature death from cardiovascular disease. Mayo Clin Proc. 2024;99:1835\u20137. https:\/\/doi.org\/10.1016\/j.mayocp.2024.07.011.","journal-title":"Mayo Clin Proc"},{"key":"4573_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejim.2023.10.009","volume":"121","author":"J Timsans","year":"2024","unstructured":"Timsans J, Kauppi JE, Kerola AM, Lehto TM, Kautiainen HJ, Kauppi MJ. Hyperuricaemia-associated all-cause mortality risk effect is increased by non-impaired kidney function - is renal hyperuricaemia less dangerous? Eur J Intern Med. 2024;121:56\u201362. https:\/\/doi.org\/10.1016\/j.ejim.2023.10.009.","journal-title":"Eur J Intern Med"},{"key":"4573_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15060356","volume":"15","author":"J Timsans","year":"2025","unstructured":"Timsans J, Kauppi J, Rantalaiho V, et al. Hyperuricemia-especially \u201cmetabolic hyperuricemia\u201d-is independently associated with a higher risk of steatotic liver disease. Metabolites. 2025;15:356. https:\/\/doi.org\/10.3390\/metabo15060356.","journal-title":"Metabolites"},{"key":"4573_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/HJH.0000000000003319","volume":"41","author":"E Casiglia","year":"2023","unstructured":"Casiglia E, Tikhonoff V, Virdis A, et al. Serum uric acid \/ serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values. J Hypertens. 2023;41:180\u20136. https:\/\/doi.org\/10.1097\/HJH.0000000000003319.","journal-title":"J Hypertens"},{"key":"4573_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082621","volume":"14","author":"J Timsans","year":"2025","unstructured":"Timsans J, Kauppi J, Rantalaiho V, et al. Serum uric acid is associated with insulin resistance in non-diabetic subjects. J Clin Med. 2025;14:2621. https:\/\/doi.org\/10.3390\/jcm14082621.","journal-title":"J Clin Med"},{"key":"4573_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000473703","volume":"137","author":"K Werner","year":"2017","unstructured":"Werner K, Pihlsg\u00e5rd M, Elmst\u00e5hl S, Legrand H, Nyman U, Christensson A. Combining cystatin C and creatinine yields a reliable glomerular filtration rate estimation in older adults in contrast to \u03b2-trace protein and \u03b22-microglobulin. Nephron. 2017;137:29\u201337. https:\/\/doi.org\/10.1159\/000473703.","journal-title":"Nephron"},{"key":"4573_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/0970-9185.105784","volume":"29","author":"S Gupta","year":"2013","unstructured":"Gupta S, Atcheson R. Opioid and chronic non-cancer pain. J Anaesthesiol Clin Pharmacol. 2013;29:6\u201312. https:\/\/doi.org\/10.4103\/0970-9185.105784.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"4573_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF02293867","volume":"43","author":"JL Fleiss","year":"1978","unstructured":"Fleiss JL, Shrout PE. Approximate interval estimation for a certain intraclass correlation coefficient. Psychometrika. 1978;43:259\u201362.","journal-title":"Psychometrika"},{"key":"4573_CR23","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1001\/jamainternmed.2018.4273","volume":"178","author":"Z Bouck","year":"2018","unstructured":"Bouck Z, Mecredy GC, Ivers NM, et al. Frequency and associations of prescription nonsteroidal anti-inflammatory drug use among patients with a musculoskeletal disorder and hypertension, heart failure, or chronic kidney disease. JAMA Intern Med. 2018;178:1516\u201325. https:\/\/doi.org\/10.1001\/jamainternmed.2018.4273.","journal-title":"JAMA Intern Med"},{"key":"4573_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/sdi.12196","volume":"27","author":"SN Davison","year":"2014","unstructured":"Davison SN, Koncicki H, Brennan F. Pain in chronic kidney disease: a scoping review. Semin Dial. 2014;27:188\u2013204. https:\/\/doi.org\/10.1111\/sdi.12196.","journal-title":"Semin Dial"},{"key":"4573_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/BOR.0000000000000679","volume":"32","author":"K Yip","year":"2020","unstructured":"Yip K, Cohen RE, Pillinger MH. Asymptomatic hyperuricemia: is it really asymptomatic? Curr Opin Rheumatol. 2020;32:71\u20139. https:\/\/doi.org\/10.1097\/BOR.0000000000000679.","journal-title":"Curr Opin Rheumatol"},{"key":"4573_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, House ME, Aati O, et al. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study. Ann Rheum Dis. 2015;74:908\u201311. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206397.","journal-title":"Ann Rheum Dis"},{"key":"4573_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105335","volume":"89","author":"M Gutierrez","year":"2022","unstructured":"Gutierrez M, Sandoval H, Bertolazzi C, et al. Update of the current role of ultrasound in asymptomatic hyperuricemia. A systematic literature review. Joint Bone Spine. 2022;89:105335. https:\/\/doi.org\/10.1016\/j.jbspin.2021.105335.","journal-title":"Joint Bone Spine"},{"key":"4573_CR28","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.semarthrit.2020.04.007","volume":"50","author":"RT Keenan","year":"2020","unstructured":"Keenan RT. The biology of urate. Semin Arthritis Rheum. 2020;50:S2\u201310. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.04.007.","journal-title":"Semin Arthritis Rheum"},{"key":"4573_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","volume":"82","author":"T Bardin","year":"2015","unstructured":"Bardin T. Hyperuricemia starts at 360 micromoles (6 mg\/dL). Joint Bone Spine. 2015;82:141\u20133. https:\/\/doi.org\/10.1016\/j.jbspin.2015.01.002.","journal-title":"Joint Bone Spine"},{"key":"4573_CR30","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/acr.23549","volume":"70","author":"IO Estevez-Garcia","year":"2018","unstructured":"Estevez-Garcia IO, Gallegos-Nava S, Vera-P\u00e9rez E, et al. Levels of cytokines and microRNAs in individuals with asymptomatic hyperuricemia and ultrasonographic findings of gout: a bench-to-bedside approach. Arthritis Care Res (Hoboken). 2018;70:1814\u201321. https:\/\/doi.org\/10.1002\/acr.23549.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4573_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.785214","volume":"14","author":"WBS Zhou","year":"2021","unstructured":"Zhou WBS, Meng J, Zhang J. Does low grade systemic inflammation have a role in chronic pain? Front Mol Neurosci. 2021;14:785214. https:\/\/doi.org\/10.3389\/fnmol.2021.785214.","journal-title":"Front Mol Neurosci"},{"key":"4573_CR32","doi-asserted-by":"publisher","first-page":"7378","DOI":"10.1038\/s41598-021-86962-0","volume":"11","author":"M Kurajoh","year":"2021","unstructured":"Kurajoh M, Fukumoto S, Yoshida S, et al. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry. Sci Rep. 2021;11:7378. https:\/\/doi.org\/10.1038\/s41598-021-86962-0.","journal-title":"Sci Rep"},{"key":"4573_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9111166","volume":"9","author":"J Hendrix","year":"2020","unstructured":"Hendrix J, Nijs J, Ickmans K, Godderis L, Ghosh M, Polli A. The interplay between oxidative stress, exercise, and pain in health and disease: potential role of autonomic regulation and epigenetic mechanisms. Antioxidants. 2020;9:1166. https:\/\/doi.org\/10.3390\/antiox9111166.","journal-title":"Antioxidants"},{"key":"4573_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/nn.3144","volume":"15","author":"IM Chiu","year":"2012","unstructured":"Chiu IM, von Hehn CA, Woolf CJ. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci. 2012;15:1063\u20137. https:\/\/doi.org\/10.1038\/nn.3144.","journal-title":"Nat Neurosci"},{"key":"4573_CR35","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1093\/rheumatology\/keab934","volume":"61","author":"PM Ten Klooster","year":"2022","unstructured":"Ten Klooster PM, Kraiss JT, Munters R, Vonkeman HE. Generalized pain hypersensitivity and associated factors in gout. Rheumatology (Oxford). 2022;61:3640\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/keab934.","journal-title":"Rheumatology (Oxford)"},{"key":"4573_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.numecd.2023.10.009","volume":"34","author":"A Maloberti","year":"2024","unstructured":"Maloberti A, Dell\u2019Oro R, Bombelli M, et al. Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study. Nutr Metab Cardiovasc Dis. 2024;34:223\u20139. https:\/\/doi.org\/10.1016\/j.numecd.2023.10.009.","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04573-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04573-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04573-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:27:17Z","timestamp":1768390037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-025-04573-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4573"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04573-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study followed the guidelines of the Declaration of Helsinki. The cohort study was approved in 2002 by the Ethics Committee of P\u00e4ij\u00e4t-H\u00e4me Central Hospital, which is located in the city of Lahti (ID number of approval: PHSP 2\/2002\/Q11 \u00a7 87). All participants gave their written informed consent prior to data collection. The use of the data gathered in the cohort study combined with registry data was approved by HUS Regional Committee on Medical Research Ethics in 2019 (ID number of approval: HUS\/1748\/20219 \u00a7 124).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}